{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:25:10Z","timestamp":1790249110200,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,2]],"date-time":"2013-12-02T00:00:00Z","timestamp":1385942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"CONACYT","award":["127777"],"award-info":[{"award-number":["127777"]}]},{"name":"CONACYT","award":["179616"],"award-info":[{"award-number":["179616"]}]},{"name":"PAPIIT-DGAPA-UNAM","award":["IN210406"],"award-info":[{"award-number":["IN210406"]}]},{"name":"PAPIIT-DGAPA-UNAM","award":["IN218111"],"award-info":[{"award-number":["IN218111"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.neuropharm.2013.11.013","type":"journal-article","created":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T10:48:45Z","timestamp":1385894925000},"page":"88-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Dopamine receptor dysregulation in hippocampus of aged rats underlies chronic pulsatile l-Dopa treatment induced cognitive and emotional alterations"],"prefix":"10.1016","volume":"82","author":[{"given":"Vito S.","family":"Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Luqu\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"J\u00e1uregui-Huerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleph A.","family":"Corona-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio P.","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ru\u00edz-Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2013.11.013_bib1","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/S0047-6374(01)00317-7","article-title":"Age-related changes of dopamine receptors in the rat hippocampus: a light microscope autoradiography study","volume":"122","author":"Amenta","year":"2001","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0896-6273(00)81056-9","article-title":"Addiction, dopamine, and the molecular mechanisms of memory","volume":"25","author":"Berke","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib4","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/mds.25135","article-title":"Living on the edge with too many mouths to feed: why dopamine neurons die","volume":"27","author":"Bolam","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib5","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s10571-007-9213-6","article-title":"Long-term L-DOPA treatment causes indiscriminate increase in dopamine levels at the cost of serotonin synthesis in discrete brain regions of rats","volume":"27","author":"Borah","year":"2007","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01376517-200604000-00006","article-title":"Palliative care in Parkinson's disease: implications for neuroscience nursing","volume":"38","author":"Bunting-Perry","year":"2006","journal-title":"J.\u00a0Neurosci. Nurs."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrn1809","article-title":"Neural plasticity in the ageing brain","volume":"7","author":"Burke","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib8","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/jnnp.52.6.724","article-title":"Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: possible role of the \u201chedonic\u201d dopamine synapse","volume":"52","author":"Cantello","year":"1989","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib9","first-page":"623","article-title":"Pharmacokinetic comparison of Sinemet and Grifoparkin (levodopa\/carbidopa 250\/25 mg) in Parkinson s disease: a single dose study","volume":"131","author":"Chana","year":"2003","journal-title":"Rev. Med. Chil."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/1098-2396(200008)37:2<125::AID-SYN7>3.0.CO;2-7","article-title":"Dopamine D(5) receptor immunolocalization in rat and monkey brain","volume":"37","author":"Ciliax","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00001756-200002280-00015","article-title":"L-DOPA-induced neurotoxic and apoptotic changes on cultured chromaffin cells","volume":"11","author":"Corona-Morales","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/jnr.10456","article-title":"Fullerene C60 and ascorbic acid protect cultured chromaffin cells against levodopa toxicity","volume":"71","author":"Corona-Morales","year":"2003","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib13","first-page":"147","article-title":"Dopamine receptors: subtypes, localization and regulation","volume":"40","author":"Creese","year":"1981","journal-title":"Fed. Proc."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.physbeh.2012.11.001","article-title":"The effect of unpredictable chronic mild stress on depressive-like behavior and on hippocampal A1 and striatal A2A adenosine receptors","volume":"109","author":"Crema","year":"2013","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1176\/ajp.149.4.443","article-title":"Depression and Parkinson's disease: a review","volume":"149","author":"Cummings","year":"1992","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0197-4580(96)00206-0","article-title":"Effect of aging on the basal expression of c-Fos, c-Jun, and Egr-1 proteins in the hippocampus","volume":"18","author":"Desjardins","year":"1997","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib18","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0006-3223(99)00177-8","article-title":"Neural plasticity to stress and antidepressant treatment","volume":"46","author":"Duman","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1006\/exnr.1996.6379","article-title":"Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease","volume":"144","author":"Elsworth","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.wco.0000137528.23126.41","article-title":"Dopamine dysregulation syndrome in Parkinson's disease","volume":"17","author":"Evans","year":"2004","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib21","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1523\/JNEUROSCI.16-06-02020.1996","article-title":"Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus","volume":"16","author":"Flores","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0304-3940(91)90732-9","article-title":"The effect of dopaminergic D1 receptor blockade during tetanization on the expression of long-term potentiation in the rat CA1 region in\u00a0vitro","volume":"129","author":"Frey","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.2042-7158.1986.tb03112.x","article-title":"Dopaminergic metabolism in various rat brain areas after L-dopa loading","volume":"38","author":"el Gemayel","year":"1986","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1254\/fpj.102.11","article-title":"Transmitter-like release and pharmacological activities of levodopa","volume":"102","author":"Goshima","year":"1993","journal-title":"Nihon Yakurigaku Zasshi"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35075076","article-title":"BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization","volume":"411","author":"Guillin","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s007020050159","article-title":"Exogenous levodopa is not toxic to elderly subjects with non-parkinsonian movement disorders: further clinical evidence","volume":"106","author":"Hagenah","year":"1999","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/cne.10525","article-title":"Neuron-specific age-related decreases in dopamine receptor subtype mRNAs","volume":"456","author":"Hemby","year":"2003","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neulet.2012.09.002","article-title":"Differential effects of osmotic and SSR149415 challenges in maternally separated and control rats: the role of vasopressin on spatial learning","volume":"528","author":"Hernandez","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00213-003-1672-y","article-title":"A\u00a0meta-analysis of the response to chronic L-dopa in patients with schizophrenia: therapeutic and heuristic implications","volume":"171","author":"Jaskiw","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0301-0082(03)00085-6","article-title":"Dopamine: a potential substrate for synaptic plasticity and memory mechanisms","volume":"69","author":"Jay","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0163-7258(01)00139-5","article-title":"Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs","volume":"90","author":"Joyce","year":"2001","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib32","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.expneurol.2004.01.012","article-title":"Loss of D3 receptors in the zitter mutant rat is not reversed by L-dopa treatment","volume":"187","author":"Joyce","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib33","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0197-4580(00)00149-4","article-title":"Age-related dopamine D2\/D3 receptor loss in extrastriatal regions of the human brain","volume":"21","author":"Kaasinen","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/(SICI)1096-9861(19981221)402:3<353::AID-CNE5>3.0.CO;2-4","article-title":"Differential regional and cellular distribution of dopamine D2-like receptors: an immunocytochemical study of subtype-specific antibodies in rat and human brain","volume":"402","author":"Khan","year":"1998","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2174\/157488407781668802","article-title":"The pharmacokinetics and pharmacodynamics of levodopa in the treatment of Parkinson's disease","volume":"2","author":"Khor","year":"2007","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ana.20125","article-title":"Levodopa: faster and better word learning in normal humans","volume":"56","author":"Knecht","year":"2004","journal-title":"Ann. Neurol."},{"issue":"Suppl.\u00a04","key":"10.1016\/j.neuropharm.2013.11.013_bib37","first-page":"14","article-title":"Dopamine dysregulation syndrome. Hypothetical application of reward system stimulation for the treatment of anhedonia in Parkinson's disease patients","volume":"255","author":"Kondo","year":"2008","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0197-0186(98)00023-0","article-title":"c-Fos as a transcription factor: a stressful (re)view from a functional map","volume":"33","author":"Kovacs","year":"1998","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib39","first-page":"903","article-title":"Cognitive impairment and dementia in patients with Parkinson disease","volume":"9","author":"Leverenz","year":"2009","journal-title":"Curr. Top Med. Chem."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/00207454.2011.633722","article-title":"Addiction-like manifestations and Parkinson's disease: a large single center 9-year experience","volume":"122","author":"Limotai","year":"2012","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130100694","article-title":"Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice","volume":"155","author":"Lucki","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib43","first-page":"572743","article-title":"Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: implications for cognitive function","volume":"2011","author":"Macdonald","year":"2011","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib44","first-page":"S136","article-title":"Dopamin: the rewarding years. Br","volume":"147","author":"Marsdan","year":"2006","journal-title":"J.\u00a0Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib45","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00702-008-0082-z","article-title":"L-dopa modulates motor cortex excitability in Alzheimer's disease patients","volume":"115","author":"Martorana","year":"2008","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib46","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1523\/JNEUROSCI.23-13-05674.2003","article-title":"Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses","volume":"23","author":"McLaughlin","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0304-3940(92)90024-2","article-title":"Distribution of D5 dopamine receptor mRNA in rat brain","volume":"145","author":"Meador-Woodruff","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cyto.a.20022","article-title":"Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images","volume":"58","author":"Meijering","year":"2004","journal-title":"Cytometry A"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib49","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1098\/rstb.2002.1264","article-title":"Elements of a neurobiological theory of the hippocampus: the role of activity-dependent synaptic plasticity in memory","volume":"358","author":"Morris","year":"2003","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib50","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1124\/jpet.102.042267","article-title":"Levodopa is toxic to dopamine neurons in an in\u00a0vitro but not an in\u00a0vivo model of oxidative stress","volume":"304","author":"Mytilineou","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib91","series-title":"Parkinson's Disease: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care","author":"National Collaborating Centre for Chronic Conditions (UK)","year":"2006"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib51","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.nbd.2010.01.012","article-title":"Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease","volume":"38","author":"Navailles","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.neuropharm.2013.11.013_bib52","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1021\/cn400046e","article-title":"Multisite intracerebral microdialysis to study the mechanism of L-DOPA induced dopamine and serotonin release in the parkinsonian brain","volume":"4","author":"Navailles","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib53","series-title":"Dopamine and Glutamate in Psychiatric Disorders","first-page":"3","article-title":"Dopamine receptors","author":"Neve","year":"2005"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.neuropharm.2013.11.013_bib54","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00019052-200312002-00002","article-title":"Dopamine: a key regulator to adapt action, emotion, motivation and cognition","volume":"16","author":"Nieoullon","year":"2003","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib55","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.physbeh.2012.02.019","article-title":"Prolame ameliorates anxiety and spatial learning and memory impairment induced by ovariectomy in rats","volume":"106","author":"Nissen","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib56","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.physbeh.2006.05.024","article-title":"Gustatory reward and the nucleus accumbens","volume":"89","author":"Norgren","year":"2006","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib57","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.410220415","article-title":"On-off phenomenon: relation to levodopa pharmacokinetics and pharmacodynamics","volume":"22","author":"Nutt","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib58","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1101\/lm.321006","article-title":"Dopaminergic modulation of the persistence of one-trial hippocampus-dependent memory","volume":"13","author":"O'Carroll","year":"2006","journal-title":"Learn Mem."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib59","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1212\/WNL.0b013e3181a1d44c","article-title":"The scientific and clinical basis for the treatment of Parkinson disease (2009)","volume":"72","author":"Olanow","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib60","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1523\/JNEUROSCI.19-04-01437.1999","article-title":"Dopamine selectively inhibits the direct cortical pathway to the CA1 hippocampal region","volume":"19","author":"Otmakhova","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib61","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos G","year":"1998"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib62","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s002130100733","article-title":"L-dopa induces dyskinesia in normal monkeys: behavioural and pharmacokinetic observations","volume":"156","author":"Pearce","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib63","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1192\/bjp.119.550.277","article-title":"L-DOPA in the treatment of depressive symptoms","volume":"119","author":"Persson","year":"1971","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib64","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fncom.2013.00013","article-title":"The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease","volume":"7","author":"Pissadaki","year":"2013","journal-title":"Front Comput. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib65","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib66","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib67","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00221-008-1654-8","article-title":"Better than normal: improved formation of long-term spatial memory in healthy rats treated with levodopa","volume":"192","author":"Reinholz","year":"2009","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib68","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00213-006-0668-9","article-title":"Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits","volume":"191","author":"Salamone","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0304-3940(80)90314-6","article-title":"Origin of dopaminergic innervation of the rat hippocampal formation","volume":"18","author":"Scatton","year":"1980","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib70","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1212\/WNL.61.6_suppl_3.S56","article-title":"Disease-modifying strategies and challenges in PD: interactive breakout sessions","volume":"61","author":"Schapira","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib71","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib72","series-title":"Molecular Pharamcology of Cell Regulation","author":"Sibley","year":"1994"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib73","series-title":"The Dopamine Receptors","first-page":"383","article-title":"Regulation of dopamine receptor function and expression","author":"Sibley","year":"1997"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib74","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/187152706784111551","article-title":"The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders","volume":"5","author":"Sokoloff","year":"2006","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib75","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/j.1875-9114.1997.tb03794.x","article-title":"Levodopa dependence and abuse in Parkinson's disease","volume":"17","author":"Spigset","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib76","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0306-4522(99)00561-8","article-title":"Immunohistochemical and neurochemical correlates of learning deficits in aged rats","volume":"96","author":"Stemmelin","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib77","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/350614a0","article-title":"Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1","volume":"350","author":"Sunahara","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib78","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1474-4422(12)70152-7","article-title":"Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment","volume":"11","author":"Svenningsson","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib79","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0361-9230(82)90145-9","article-title":"The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat","volume":"9","author":"Swanson","year":"1982","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib80","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0306-4522(99)00010-X","article-title":"A\u00a0double dissociation within the hippocampus of dopamine D1\/D5 receptor and beta-adrenergic receptor contributions to the persistence of long-term potentiation","volume":"92","author":"Swanson-Park","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib81","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1476-5381.2009.00585.x","article-title":"Open questions in current models of antidepressant action","volume":"159","author":"Tanti","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib82","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1126\/science.272.5264.1017","article-title":"Increase in single L-type calcium channels in hippocampal neurons during aging","volume":"272","author":"Thibault","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib83","doi-asserted-by":"crossref","first-page":"e11038","DOI":"10.1371\/journal.pone.0011038","article-title":"Altered ratio of D1 and D2 dopamine receptors in mouse striatum is associated with behavioral sensitization to cocaine","volume":"5","author":"Thompson","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib84","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.tins.2004.07.010","article-title":"Ca2+ regulation and gene expression in normal brain aging","volume":"27","author":"Toescu","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib85","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ana.1099","article-title":"Levodopa induces dyskinesias in normal squirrel monkeys","volume":"50","author":"Togasaki","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib86","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF00187257","article-title":"Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant","volume":"93","author":"Willner","year":"1987","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib87","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.neurol.2012.06.014","article-title":"Addictive behaviors and Parkinson's disease","volume":"168","author":"Witjas","year":"2012","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib88","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.neuron.2005.01.010","article-title":"Reward-related FMRI activation of dopaminergic midbrain is associated with enhanced hippocampus-dependent long-term memory formation","volume":"45","author":"Wittmann","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2013.11.013_bib89","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neulet.2010.06.071","article-title":"Influence of dopamine D3 receptor knockout on age-related decline of spatial memory","volume":"481","author":"Xing","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2013.11.013_bib90","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/jnr.21580","article-title":"Maternal hyperthyroidism in rats impairs stress coping of adult offspring","volume":"86","author":"Zhang","year":"2008","journal-title":"J.\u00a0Neurosci. Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813005376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813005376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T15:45:36Z","timestamp":1716219936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390813005376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":90,"alternative-id":["S0028390813005376"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.11.013","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopamine receptor dysregulation in hippocampus of aged rats underlies chronic pulsatile l-Dopa treatment induced cognitive and emotional alterations","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}